Log in

FRA:HNR1Hannover Re Stock Price, Forecast & News

€153.10
-0.30 (-0.20 %)
(As of 07/2/2020 05:44 AM ET)
Add
Compare
Today's Range
€149.70
Now: €153.10
€153.70
50-Day Range
€131.40
MA: €148.94
€165.70
52-Week Range
€94.75
Now: €153.10
€116.37
Volume139,498 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities. This segment also provides risk solutions for casualty and property, as well as for agricultural, livestock, and bloodstock businesses; aviation and space business; and marine and offshore energy business. The Life & Health Reinsurance segment offers credit life, enhanced annuities, group life and health, 60+, and Sharia-compliant Takaful reinsurance products. This segment also provides risk solutions in the areas of critical illness, disability, health, longevity, long term care, and mortality. In addition, it offers various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and divestiture of non-core businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. The company was founded in 1966 and is headquartered in Hanover, Germany. Hannover Rück SE is a subsidiary of Talanx AG.
Read More
Hannover Re logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.9Community Rank: 1.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars


Industry, Sector and Symbol

Industry Insurance - Reinsurance
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+49-511-56040

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees3,317
Next Earnings DateN/A
OptionableNot Optionable

Receive HNR1 News and Ratings via Email

Sign-up to receive the latest news and ratings for HNR1 and its competitors with MarketBeat's FREE daily newsletter.

Hannover Re (FRA:HNR1) Frequently Asked Questions

How has Hannover Re's stock been impacted by COVID-19 (Coronavirus)?

Hannover Re's stock was trading at €140.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, HNR1 stock has increased by 9.0% and is now trading at €153.10. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Hannover Re?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hannover Re in the last year. There are currently 3 sell ratings, 12 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Hannover Re.

What price target have analysts set for HNR1?

16 brokers have issued twelve-month price targets for Hannover Re's shares. Their forecasts range from €120.00 to €175.00. On average, they anticipate Hannover Re's share price to reach €138.93 in the next twelve months. This suggests that the stock has a possible downside of 9.3%. View analysts' price targets for Hannover Re.

Has Hannover Re been receiving favorable news coverage?

Media stories about HNR1 stock have trended very negative on Thursday, InfoTrie reports. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Hannover Re earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news about Hannover Re.

Who are some of Hannover Re's key competitors?

What other stocks do shareholders of Hannover Re own?

Who are Hannover Re's key executives?

Hannover Re's management team includes the following people:
  • Mr. Ulrich Wallin, Chairman of the Exec. Board & CEO (Age 65)
  • Mr. Roland Helmut Vogel, CFO & Member of the Exec. Board (Age 60)
  • Dr. Michael Pickel, Member of the Exec. Board (Age 59)
  • Dr. Klaus Wilhelm Miller, Member of the Exec. Board (Age 59)
  • Mr. Claude Jacques Chèvre, Member of the Exec. Board (Age 52)

What is Hannover Re's stock symbol?

Hannover Re trades on the FRA under the ticker symbol "HNR1."

What is Hannover Re's stock price today?

One share of HNR1 stock can currently be purchased for approximately €153.10.

What is Hannover Re's official website?

The official website for Hannover Re is www.hannover-rueck.de.

How can I contact Hannover Re?

Hannover Re's mailing address is Karl-Wiechert-Allee 50, HANNOVER, 30625, Germany. The company can be reached via phone at +49-511-56040.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.